COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142,016 | -27.8% | 37,972 | -17.6% | 0.00% | 0.0% |
| Q2 2023 | $196,805 | -24.6% | 46,090 | +20.8% | 0.00% | 0.0% |
| Q1 2023 | $261,049 | +71814.3% | 38,165 | -16.8% | 0.00% | -50.0% |
| Q4 2022 | $363 | -16.2% | 45,851 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $433 | -99.9% | 45,060 | +6.3% | 0.00% | +100.0% |
| Q2 2022 | $307,000 | -44.4% | 42,398 | -0.8% | 0.00% | -50.0% |
| Q1 2022 | $552,000 | -6.1% | 42,759 | +15.9% | 0.00% | 0.0% |
| Q4 2021 | $588,000 | -1.0% | 36,890 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $594,000 | +9.8% | 36,890 | -5.6% | 0.00% | 0.0% |
| Q2 2021 | $541,000 | -3.2% | 39,089 | +2.2% | 0.00% | 0.0% |
| Q1 2021 | $559,000 | -15.6% | 38,239 | +0.4% | 0.00% | -33.3% |
| Q4 2020 | $662,000 | 0.0% | 38,081 | +5.4% | 0.00% | 0.0% |
| Q3 2020 | $662,000 | +3.3% | 36,126 | +0.7% | 0.00% | 0.0% |
| Q2 2020 | $641,000 | – | 35,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |